Clinical Trials Browser

Phase 3 × Mesothelioma, Malignant × atezolizumab × Clear all

NCT04996017 2025-03-13

AtezoMeso

Phase 3 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma